CDK7 inhibitors draw attention as next-generation anticancer drugs… Pharmaceutical industry joins in development
(Health Korea News / Lee Chung-man) As CDK7 inhibitors are gaining attention as next-generation anticancer drugs, pharmaceutical companies are jumping into the development of treatments one after another. The CDK protein family is a major enzyme that controls the cell … Read more